ITGAV and thyroid cancer: In the ECM group, TNC was in a central position, and its main interaction target was Integrin Alpha V (ITGAV), a protein expressed in thyroid tissues higher than in other tissues in the human body, suggesting that it specifically influences the differentiation of thyroid cancer through the phenotype of extracellular matrix (Supplementary Figure 7C).